Loading...
Review of the Clinical Studies Using the 21-Gene Assay
PURPOSE. A major challenge in treating early-stage hormone receptor (HR)(+) breast cancer is selecting women who, after initial surgery, do not require chemotherapy. Better prognostic and predictive tests are needed. The 21-gene assay is the only widely commercially available gene signature that can...
Na minha lista:
Main Authors: | , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
AlphaMed Press
2010
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227976/ https://ncbi.nlm.nih.gov/pubmed/20421266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0277 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|